Neuroscience News

Using EEG to measure brain activity, Stanford researchers and their collaborators applied artificial intelligence to help determine the best depression treatment for individual patients.

NIH-funded research used machine learning algorithm to predict individual treatment response.

Making changes to the molecular messengers that create proteins might offer flexible therapies for cancer, pain or high cholesterol, in addition to genetic disorders.

A new technique for systematically surveying proteins on the outer surface of cells, which act like molecular social cues to guide cell-cell interactions and assembly into tissues and organs.

The online world can be isolating — and it can even contribute to rage, depression and extremism. But technology and the web can also be used to foster community, understanding and even spirituality.

The oxygen we inhale, combined with the food we eat, generates the energy we need to live, think and blog.

Stanford scientists have identified specific biological pathways along which individuals age over time.

From a painful pinch to a soft caress, scientists are zooming in on the pressure-sensitive proteins that allow cells to detect tension and pressure.

A new study has identified T cells targeting the Epstein-Barr virus in autopsied Alzheimer's brains and in cerebrospinal fluid of Alzheimer's patients.

As long as it took you to read that headline. Or shorter. Or it might not exist at all.

Exercise, including Qigong and Tai Chi, can produce impressive results.

Optogenetics has revolutionized neuroscience, and materials scientists have now found a way to do it even better.

A pair of advances in brain imaging technology will help neuroscientists track electrical activity in neurons with a new level of clarity.

In the presence of alcohol, a defective version of the aldehyde dehydrogenase 2 gene in human cell cultures and mice leads to biochemical changes associated with Alzheimer’s disease.

MDMA can instill in users an unguarded comfort among even the most unfamiliar of faces but is also prone to abuse. Stanford researchers have driven a wedge between these two aspects of the drug.

By Bruce Goldman